RIGL logo

Rigel Pharmaceuticals (RIGL) Total Assets

Annual Total Assets

$163.98 M
+$46.75 M+39.88%

December 31, 2024

Summary

Performance

1-Year Change

+39.88%

3-Year Change

-2%

5-Year Change

+11.12%

15-Year Change

+37.67%

RIGL Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.98%
RIGL annual total assets is higher than 51.98% of companies in Healthcare sector

High & Low

All-time High

$310.04 M
RIGL annual total assets is currently -47.11% below its historical high of $310.04 million

3-Year Low

$117.22 M
RIGL annual total assets is currently +39.88% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RIGL previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RIGL next annual earnings announcement has not yet been scheduled

OtherRIGLbalance sheetmetrics:

Annual Current Assets

$135.10 M
RIGL annual total current assets is $135.10 million

Annual Non Current Assets

$28.87 M
RIGL annual long term assets is $28.87 million

Annual Total Liabilities

$160.69 M
RIGL annual total liabilities is $160.69 million

Annual Current Liabilities

$63.30 M
RIGL annual total current liabilities is $63.30 million

Quarterly Total Assets

$163.98 M
+$24.56 M+17.61%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

RIGL Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.94%
RIGL quarterly total assets is higher than 51.94% of companies in Healthcare sector

High & Low

All-time High

$310.04 M
RIGL quarterly total assets is currently -47.11% below its historical high of $310.04 million

3-Year Low

$115.32 M
RIGL quarterly total assets is currently +42.19% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RIGL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
RIGL next earnings announcement is scheduled for May 7, 2025

OtherRIGLbalance sheetmetrics:

Quarterly Current Assets

$135.10 M
RIGL quarterly total current assets is $135.10 million

Quarterly Non Current Assets

$28.87 M
RIGL quarterly long term assets is $28.87 million

Quarterly Total Liabilities

$160.69 M
RIGL quarterly total liabilities is $160.69 million

Quarterly Current Liabilities

$63.30 M
RIGL quarterly total current liabilities is $63.30 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$163.98 M
RIGL annual total assets is $163.98 million

Annual Non Current Assets

$28.87 M
RIGL annual long term assets is $28.87 million

Annual Current Assets

$135.10 M
RIGL annual total current assets is $135.10 million

RIGL Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+39.9%0.0%
3 y3 years-2.0%0.0%
5 y5 years+11.1%0.0%

RIGL Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.0%+39.9%-2.0%+42.2%
5 y5-year-2.0%+48.6%-24.1%+48.6%
alltimeall time-47.1%+855.1%-47.1%+401.8%

Rigel Pharmaceuticals Total Assets History

DateAnnualQuarterly
Dec 2024
$163.98 M(+39.9%)
$163.98 M(+17.6%)
Sep 2024
-
$139.42 M(+8.6%)
Jun 2024
-
$128.41 M(+1.5%)
Mar 2024
-
$126.52 M(+7.9%)
Dec 2023
$117.22 M(-12.7%)
$117.22 M(+1.6%)
Sep 2023
-
$115.32 M(-1.5%)
Jun 2023
-
$117.09 M(-5.3%)
Mar 2023
-
$123.61 M(-7.9%)
Dec 2022
$134.28 M(-19.8%)
$134.28 M(+16.1%)
Sep 2022
-
$115.61 M(-9.7%)
Jun 2022
-
$128.00 M(-14.1%)
Mar 2022
-
$149.07 M(-10.9%)
Dec 2021
$167.33 M(+51.6%)
$167.33 M(-10.3%)
Sep 2021
-
$186.52 M(-7.5%)
Jun 2021
-
$201.60 M(-6.7%)
Mar 2021
-
$215.99 M(+95.7%)
Dec 2020
$110.38 M(-25.2%)
$110.38 M(-10.3%)
Sep 2020
-
$123.06 M(-10.9%)
Jun 2020
-
$138.03 M(-3.7%)
Mar 2020
-
$143.36 M(-2.9%)
Dec 2019
$147.57 M(+6.1%)
$147.57 M(-5.4%)
Sep 2019
-
$156.06 M(-0.1%)
Jun 2019
-
$156.16 M(-9.6%)
Mar 2019
-
$172.78 M(+24.2%)
Dec 2018
$139.11 M(+16.8%)
$139.11 M(+12.9%)
Sep 2018
-
$123.17 M(-12.8%)
Jun 2018
-
$141.22 M(+42.9%)
Mar 2018
-
$98.81 M(-17.0%)
Dec 2017
$119.11 M(+52.4%)
$119.11 M(+67.2%)
Sep 2017
-
$71.25 M(-16.6%)
Jun 2017
-
$85.48 M(-15.6%)
Mar 2017
-
$101.33 M(+29.7%)
Dec 2016
$78.13 M(-40.7%)
$78.13 M(-11.9%)
Sep 2016
-
$88.64 M(-10.8%)
Jun 2016
-
$99.32 M(-8.3%)
Mar 2016
-
$108.28 M(-17.8%)
Dec 2015
$131.75 M(-14.5%)
$131.75 M(-5.3%)
Sep 2015
-
$139.17 M(-6.2%)
Jun 2015
-
$148.35 M(-10.5%)
Mar 2015
-
$165.69 M(+7.5%)
Dec 2014
$154.13 M(-31.8%)
$154.13 M(-5.6%)
Sep 2014
-
$163.22 M(-10.5%)
Jun 2014
-
$182.43 M(-10.3%)
Mar 2014
-
$203.29 M(-10.1%)
Dec 2013
$226.06 M(-27.1%)
$226.06 M(-5.6%)
Sep 2013
-
$239.54 M(-8.5%)
Jun 2013
-
$261.67 M(-7.5%)
Mar 2013
-
$282.94 M(-8.7%)
DateAnnualQuarterly
Dec 2012
$310.04 M(+20.6%)
$310.04 M(+59.6%)
Sep 2012
-
$194.32 M(-9.4%)
Jun 2012
-
$214.36 M(-8.4%)
Mar 2012
-
$233.91 M(-9.0%)
Dec 2011
$257.11 M(+37.7%)
$257.11 M(-6.8%)
Sep 2011
-
$275.87 M(-4.8%)
Jun 2011
-
$289.87 M(+75.0%)
Mar 2011
-
$165.67 M(-11.3%)
Dec 2010
$186.69 M(+32.6%)
$186.69 M(-4.7%)
Jun 2010
-
$195.91 M(-9.8%)
Mar 2010
-
$217.15 M(+54.3%)
Dec 2009
$140.74 M(-2.2%)
$140.74 M(-14.3%)
Sep 2009
-
$164.29 M(+86.2%)
Jun 2009
-
$88.22 M(-22.6%)
Mar 2009
-
$114.03 M(-20.7%)
Dec 2008
$143.86 M(+24.2%)
$143.86 M(-14.7%)
Sep 2008
-
$168.58 M(-13.4%)
Jun 2008
-
$194.68 M(-10.7%)
Mar 2008
-
$218.03 M(+88.3%)
Dec 2007
$115.79 M(+2.3%)
$115.79 M(-3.3%)
Sep 2007
-
$119.68 M(-10.8%)
Jun 2007
-
$134.16 M(+37.7%)
Mar 2007
-
$97.45 M(-13.9%)
Dec 2006
$113.24 M(-23.3%)
$113.24 M(-9.0%)
Sep 2006
-
$124.37 M(-5.2%)
Jun 2006
-
$131.22 M(-5.2%)
Mar 2006
-
$138.47 M(-6.2%)
Dec 2005
$147.67 M(+87.3%)
$147.67 M(+8.6%)
Sep 2005
-
$136.02 M(+98.2%)
Jun 2005
-
$68.63 M(-14.6%)
Mar 2005
-
$80.38 M(+2.0%)
Dec 2004
$78.82 M(+42.0%)
$78.82 M(-0.8%)
Sep 2004
-
$79.48 M(-12.1%)
Jun 2004
-
$90.39 M(-11.6%)
Mar 2004
-
$102.28 M(+84.2%)
Dec 2003
$55.52 M(+25.2%)
$55.52 M(-16.5%)
Sep 2003
-
$66.49 M(-1.1%)
Jun 2003
-
$67.25 M(+105.8%)
Mar 2003
-
$32.68 M(-26.3%)
Dec 2002
$44.34 M(-4.5%)
$44.34 M(-17.6%)
Sep 2002
-
$53.83 M(-16.0%)
Jun 2002
-
$64.06 M(-13.6%)
Mar 2002
-
$74.16 M(+59.7%)
Dec 2001
$46.45 M(-27.7%)
$46.45 M(-12.2%)
Sep 2001
-
$52.88 M(-2.7%)
Jun 2001
-
$54.33 M(-8.5%)
Mar 2001
-
$59.40 M(-7.6%)
Dec 2000
$64.26 M(+274.3%)
$64.26 M
Dec 1999
$17.17 M
-

FAQ

  • What is Rigel Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Rigel Pharmaceuticals?
  • What is Rigel Pharmaceuticals annual total assets year-on-year change?
  • What is Rigel Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Rigel Pharmaceuticals?
  • What is Rigel Pharmaceuticals quarterly total assets year-on-year change?

What is Rigel Pharmaceuticals annual total assets?

The current annual total assets of RIGL is $163.98 M

What is the all time high annual total assets for Rigel Pharmaceuticals?

Rigel Pharmaceuticals all-time high annual total assets is $310.04 M

What is Rigel Pharmaceuticals annual total assets year-on-year change?

Over the past year, RIGL annual total assets has changed by +$46.75 M (+39.88%)

What is Rigel Pharmaceuticals quarterly total assets?

The current quarterly total assets of RIGL is $163.98 M

What is the all time high quarterly total assets for Rigel Pharmaceuticals?

Rigel Pharmaceuticals all-time high quarterly total assets is $310.04 M

What is Rigel Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, RIGL quarterly total assets has changed by $0.00 (0.00%)